{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:06:18Z","timestamp":1780117578632,"version":"3.54.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:00Z","timestamp":1495497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:00Z","timestamp":1495497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The proliferation and migration of vascular smooth muscle cells (VSMCs) play an essential role during the development of cardiovascular diseases (CVDs). While many factors potentially contribute to the abnormal activation of VSMCs, hyperglycemia is generally believed to be a major causative factor. On the other hand, FAM3B (named PANDER for its secretory form) is a uniquely structured protein strongly expressed within and secreted from the endocrine pancreas. FAM3B is co-secreted with insulin from the \u03b2-cell upon glucose stimulation and regulates glucose homeostasis. In the present study, we sought to determine the roles of FAM3B in the regulation of VSMC physiology, especially under the hyperglycemic condition. We found that FAM3B expression was induced by hyperglycemia both <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>. FAM3B knockdown inhibited, whereas FAM3B overexpression accelerated VSMC proliferation and migration. At the molecular level, FAM3B inhibited miR-322-5p expression, and enforced expression of miR-322-5p antagonized FAM3B-induced VSMC proliferation and migration, suggesting that FAM3B facilitated VSMC pathological activation via miR-322-5p. Taken together, FAM3B mediates high glucose-induced VSMC proliferation and migration via inhibition of miR-322-5p. Thus, FAM3B may therefore serve as a novel therapeutic target for diabetes-related CVDs.<\/jats:p>","DOI":"10.1038\/s41598-017-02683-3","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T11:51:34Z","timestamp":1495021894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["FAM3B mediates high glucose-induced vascular smooth muscle cell proliferation and migration via inhibition of miR-322-5p"],"prefix":"10.1038","volume":"7","author":[{"given":"Wenxiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"key":"2683_CR1","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1161\/01.ATV.10.6.966","volume":"10","author":"J Thyberg","year":"1990","unstructured":"Thyberg, J., Hedin, U., Sjolund, M., Palmberg, L. & Bottger, B. A. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis \n                           10, 966\u2013990 (1990).","journal-title":"Arteriosclerosis"},{"key":"2683_CR2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1152\/physrev.00041.2003","volume":"84","author":"GK Owens","year":"2004","unstructured":"Owens, G. K., Kumar, M. S. & Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev \n                           84, 767\u2013801 (2004).","journal-title":"Physiol Rev"},{"key":"2683_CR3","first-page":"86","volume":"39","author":"A Rudijanto","year":"2007","unstructured":"Rudijanto, A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones \n                           39, 86\u201393 (2007).","journal-title":"Acta Med Indones"},{"key":"2683_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/01.CIR.98.1.82","volume":"98","author":"RC Braun-Dullaeus","year":"1998","unstructured":"Braun-Dullaeus, R. C., Mann, M. J. & Dzau, V. J. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation \n                           98, 82\u201389 (1998).","journal-title":"Circulation"},{"key":"2683_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0952-3278(99)80022-2","volume":"60","author":"BM Egan","year":"1999","unstructured":"Egan, B. M., Lu, G. & Greene, E. L. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Prostaglandins Leukot Essent Fatty Acids \n                           60, 411\u2013420 (1999).","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2683_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/362801a0","volume":"362","author":"R Ross","year":"1993","unstructured":"Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature \n                           362, 801\u2013809 (1993).","journal-title":"Nature"},{"key":"2683_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","volume":"78","author":"AH Sprague","year":"2009","unstructured":"Sprague, A. H. & Khalil, R. A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol \n                           78, 539\u2013552 (2009).","journal-title":"Biochem Pharmacol"},{"key":"2683_CR8","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1038\/sj.onc.1210414","volume":"26","author":"S Meloche","year":"2007","unstructured":"Meloche, S. & Pouyssegur, J. The ERK1\/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene \n                           26, 3227\u20133239 (2007).","journal-title":"Oncogene"},{"key":"2683_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0024-3205(02)02182-3","volume":"72","author":"M Suzuki","year":"2002","unstructured":"Suzuki, M., Akimoto, K. & Hattori, Y. Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells. Life Sci \n                           72, 59\u201366 (2002).","journal-title":"Life Sci"},{"key":"2683_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2337\/diacare.22.2.233","volume":"22","author":"M Coutinho","year":"1999","unstructured":"Coutinho, M., Gerstein, H. C., Wang, Y. & Yusuf, S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care \n                           22, 233\u2013240 (1999).","journal-title":"Diabetes Care"},{"key":"2683_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/er.2001-0039","volume":"23","author":"JL Evans","year":"2002","unstructured":"Evans, J. L., Goldfine, I. D., Maddux, B. A. & Grodsky, G. M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev \n                           23, 599\u2013622 (2002).","journal-title":"Endocr Rev"},{"key":"2683_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI3326","volume":"103","author":"M Igarashi","year":"1999","unstructured":"Igarashi, M. et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest \n                           103, 185\u2013195 (1999).","journal-title":"J Clin Invest"},{"key":"2683_CR13","doi-asserted-by":"publisher","first-page":"4S","DOI":"10.1016\/S0002-9343(98)00205-8","volume":"105","author":"WA Hsueh","year":"1998","unstructured":"Hsueh, W. A. & Law, R. E. Cardiovascular risk continuum: implications of insulin resistance and diabetes. Am J Med \n                           105, 4S\u201314S (1998).","journal-title":"Am J Med"},{"key":"2683_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2337\/diabetes.54.2.540","volume":"54","author":"H Li","year":"2005","unstructured":"Li, H., Telemaque, S., Miller, R. E. & Marsh, J. D. High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes \n                           54, 540\u2013545 (2005).","journal-title":"Diabetes"},{"key":"2683_CR15","doi-asserted-by":"publisher","first-page":"C422","DOI":"10.1152\/ajpcell.00577.2001","volume":"283","author":"H Sakuma","year":"2002","unstructured":"Sakuma, H. et al. High glucose inhibits apoptosis in human coronary artery smooth muscle cells by increasing bcl-xL and bfl-1\/A1. Am J Physiol Cell Physiol \n                           283, C422\u2013428 (2002).","journal-title":"Am J Physiol Cell Physiol"},{"key":"2683_CR16","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1210\/en.2011-0155","volume":"152","author":"J Ning","year":"2011","unstructured":"Ning, J., Xi, G. & Clemmons, D. R. Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells. Endocrinology \n                           152, 3143\u20133154 (2011).","journal-title":"Endocrinology"},{"key":"2683_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/geno.2002.6816","volume":"80","author":"Y Zhu","year":"2002","unstructured":"Zhu, Y. et al. Cloning, expression, and initial characterization of a novel cytokine-like gene family. Genomics \n                           80, 144\u2013150 (2002).","journal-title":"Genomics"},{"key":"2683_CR18","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.2337\/diabetes.52.9.2296","volume":"52","author":"X Cao","year":"2003","unstructured":"Cao, X. et al. Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells. Diabetes \n                           52, 2296\u20132303 (2003).","journal-title":"Diabetes"},{"key":"2683_CR19","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.2337\/diabetes.54.11.3217","volume":"54","author":"J Yang","year":"2005","unstructured":"Yang, J. et al. Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells. Diabetes \n                           54, 3217\u20133228 (2005).","journal-title":"Diabetes"},{"key":"2683_CR20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1210\/en.2007-0106","volume":"149","author":"O Wang","year":"2008","unstructured":"Wang, O. et al. Mechanisms of glucose-induced expression of pancreatic-derived factor in pancreatic beta-cells. Endocrinology \n                           149, 672\u2013680 (2008).","journal-title":"Endocrinology"},{"key":"2683_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbaexp.2005.07.003","volume":"1730","author":"BR Burkhardt","year":"2005","unstructured":"Burkhardt, B. R. et al. Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoter. Biochim Biophys Acta \n                           1730, 215\u2013225 (2005).","journal-title":"Biochim Biophys Acta"},{"key":"2683_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.gene.2005.10.040","volume":"369","author":"BR Burkhardt","year":"2006","unstructured":"Burkhardt, B. R. et al. PANDER-induced cell-death genetic networks in islets reveal central role for caspase-3 and cyclin-dependent kinase inhibitor 1A (p21). Gene \n                           369, 134\u2013141 (2006).","journal-title":"Gene"},{"key":"2683_CR23","doi-asserted-by":"publisher","first-page":"E543","DOI":"10.1152\/ajpendo.00113.2005","volume":"289","author":"X Cao","year":"2005","unstructured":"Cao, X. et al. Effects of overexpression of pancreatic derived factor (FAM3B) in isolated mouse islets and insulin-secreting betaTC3 cells. Am J Physiol Endocrinol Metab \n                           289, E543\u2013550 (2005).","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2683_CR24","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.febslet.2011.04.005","volume":"585","author":"CE Robert-Cooperman","year":"2011","unstructured":"Robert-Cooperman, C. E., Wilson, C. G. & Burkhardt, B. R. PANDER KO mice on high-fat diet are glucose intolerant yet resistant to fasting hyperglycemia and hyperinsulinemia. FEBS Lett \n                           585, 1345\u20131349 (2011).","journal-title":"FEBS Lett"},{"key":"2683_CR25","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1210\/en.2010-0379","volume":"151","author":"CG Wilson","year":"2010","unstructured":"Wilson, C. G. et al. Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice. Endocrinology \n                           151, 5174\u20135184 (2010).","journal-title":"Endocrinology"},{"key":"2683_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2003.10.004","volume":"64","author":"HY Jeong","year":"2004","unstructured":"Jeong, H. Y. & Kim, C. D. p22phox-derived superoxide mediates enhanced proliferative capacity of diabetic vascular smooth muscle cells. Diabetes Res Clin Pract \n                           64, 1\u201310 (2004).","journal-title":"Diabetes Res Clin Pract"},{"key":"2683_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/MOH.0b013e3283523e57","volume":"19","author":"H Kang","year":"2012","unstructured":"Kang, H. & Hata, A. MicroRNA regulation of smooth muscle gene expression and phenotype. Curr Opin Hematol \n                           19, 224\u2013231 (2012).","journal-title":"Curr Opin Hematol"},{"key":"2683_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12265-010-9164-z","volume":"3","author":"C Zhang","year":"2010","unstructured":"Zhang, C. MicroRNAs in vascular biology and vascular disease. J Cardiovasc Transl Res \n                           3, 235\u2013240 (2010).","journal-title":"J Cardiovasc Transl Res"},{"key":"2683_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/toxsci\/kfu271","volume":"144","author":"H Gu","year":"2015","unstructured":"Gu, H. et al. The miR-322-TRAF3 circuit mediates the pro-apoptotic effect of high glucose on neural stem cells. Toxicol Sci \n                           144, 186\u2013196 (2015).","journal-title":"Toxicol Sci"},{"key":"2683_CR30","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/cvr\/cvt045","volume":"98","author":"E Merlet","year":"2013","unstructured":"Merlet, E. et al. miR-424\/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Cardiovasc Res \n                           98, 458\u2013468 (2013).","journal-title":"Cardiovasc Res"},{"key":"2683_CR31","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1091\/mbc.E10-01-0062","volume":"21","author":"S Sarkar","year":"2010","unstructured":"Sarkar, S., Dey, B. K. & Dutta, A. MiR-322\/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell \n                           21, 2138\u20132149 (2010).","journal-title":"Mol Biol Cell"},{"key":"2683_CR32","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.febslet.2011.05.059","volume":"585","author":"CG Wilson","year":"2011","unstructured":"Wilson, C. G., Robert-Cooperman, C. E. & Burkhardt, B. R. PANcreatic-DERived factor: novel hormone PANDERing to glucose regulation. FEBS Lett \n                           585, 2137\u20132143 (2011).","journal-title":"FEBS Lett"},{"key":"2683_CR33","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/hep.24295","volume":"53","author":"J Li","year":"2011","unstructured":"Li, J. et al. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. Hepatology \n                           53, 1906\u20131916 (2011).","journal-title":"Hepatology"},{"key":"2683_CR34","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1016\/j.febslet.2009.08.008","volume":"583","author":"J Yang","year":"2009","unstructured":"Yang, J. et al. PANDER binds to the liver cell membrane and inhibits insulin signaling in HepG2 cells. FEBS Lett \n                           583, 3009\u20133015 (2009).","journal-title":"FEBS Lett"},{"key":"2683_CR35","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel, W. B. & McGee, D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA \n                           241, 2035\u20132038 (1979).","journal-title":"JAMA"},{"key":"2683_CR36","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2337\/diab.41.11.1464","volume":"41","author":"B Williams","year":"1992","unstructured":"Williams, B. & Schrier, R. W. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes \n                           41, 1464\u20131472 (1992).","journal-title":"Diabetes"},{"key":"2683_CR37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","volume":"318","author":"M Brownlee","year":"1988","unstructured":"Brownlee, M., Cerami, A. & Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med \n                           318, 1315\u20131321 (1988).","journal-title":"N Engl J Med"},{"key":"2683_CR38","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.2174\/1381612811319320005","volume":"19","author":"TV Fiorentino","year":"2013","unstructured":"Fiorentino, T. V., Prioletta, A., Zuo, P. & Folli, F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des \n                           19, 5695\u20135703 (2013).","journal-title":"Curr Pharm Des"},{"key":"2683_CR39","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/hrt.2003.029389","volume":"90","author":"AM Shah","year":"2004","unstructured":"Shah, A. M. & Channon, K. M. Free radicals and redox signalling in cardiovascular disease. Heart \n                           90, 486\u2013487 (2004).","journal-title":"Heart"},{"key":"2683_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0021-9150(03)00140-0","volume":"168","author":"AK Death","year":"2003","unstructured":"Death, A. K., Fisher, E. J., McGrath, K. C. & Yue, D. K. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis \n                           168, 263\u2013269 (2003).","journal-title":"Atherosclerosis"},{"key":"2683_CR41","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.biocel.2012.12.003","volume":"45","author":"H Mou","year":"2013","unstructured":"Mou, H. et al. Knockdown of FAM3B triggers cell apoptosis through p53-dependent pathway. Int J Biochem Cell Biol \n                           45, 684\u2013691 (2013).","journal-title":"Int J Biochem Cell Biol"},{"key":"2683_CR42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.canlet.2012.09.026","volume":"328","author":"Z Li","year":"2013","unstructured":"Li, Z. et al. A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression. Cancer Lett \n                           328, 278\u2013284 (2013).","journal-title":"Cancer Lett"},{"key":"2683_CR43","doi-asserted-by":"publisher","first-page":"e80300","DOI":"10.1371\/journal.pone.0080300","volume":"8","author":"C Oneyama","year":"2013","unstructured":"Oneyama, C. et al. MiR-424\/503-mediated Rictor upregulation promotes tumor progression. PLoS One \n                           8, e80300 (2013).","journal-title":"PLoS One"},{"key":"2683_CR44","doi-asserted-by":"crossref","unstructured":"Ross, J. S., Stagliano, N. E., Donovan, M. J., Breitbart, R. E. & Ginsburg, G. S. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci \n                           947, 271\u2013292; discussion 292\u2013273 (2001).","DOI":"10.1111\/j.1749-6632.2001.tb03949.x"},{"key":"2683_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0165-1110(90)90004-U","volume":"239","author":"ES Hansen","year":"1990","unstructured":"Hansen, E. S. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7\/1\/2. Shared risk factors for cancer and atherosclerosis\u2013a review of the epidemiological evidence. Mutat Res \n                           239, 163\u2013179 (1990).","journal-title":"Mutat Res"},{"key":"2683_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev.med.49.1.437","volume":"49","author":"SM Schwartz","year":"1998","unstructured":"Schwartz, S. M. & Murry, C. E. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med \n                           49, 437\u2013460 (1998).","journal-title":"Annu Rev Med"},{"key":"2683_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0021-9150(99)00457-8","volume":"152","author":"ER O\u2019Brien","year":"2000","unstructured":"O\u2019Brien, E. R. et al. Replication in restenotic atherectomy tissue. Atherosclerosis \n                           152, 117\u2013126 (2000).","journal-title":"Atherosclerosis"},{"key":"2683_CR48","first-page":"1760","volume":"30","author":"GP Warwick","year":"1971","unstructured":"Warwick, G. P. Effect of the cell cycle on carcinogenesis. Fed Proc \n                           30, 1760\u20131765 (1971).","journal-title":"Fed Proc"},{"key":"2683_CR49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/10408369891234282","volume":"35","author":"MC Chia","year":"1998","unstructured":"Chia, M. C. The role of adhesion molecules in atherosclerosis. Crit Rev Clin Lab Sci \n                           35, 573\u2013602 (1998).","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2683_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/0-306-46817-4_11","volume":"465","author":"Y Ohene-Abuakwa","year":"2000","unstructured":"Ohene-Abuakwa, Y. & Pignatelli, M. Adhesion molecules in cancer biology. Adv Exp Med Biol \n                           465, 115\u2013126 (2000).","journal-title":"Adv Exp Med Biol"},{"key":"2683_CR51","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1161\/01.RES.59.6.633","volume":"59","author":"D Gordon","year":"1986","unstructured":"Gordon, D., Mohai, L. G. & Schwartz, S. M. Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells. Circ Res \n                           59, 633\u2013644 (1986).","journal-title":"Circ Res"},{"key":"2683_CR52","doi-asserted-by":"publisher","first-page":"648","DOI":"10.2337\/diabetes.54.3.648","volume":"54","author":"M Gaster","year":"2005","unstructured":"Gaster, M., Rustan, A. C. & Beck-Nielsen, H. Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. Diabetes \n                           54, 648\u2013656 (2005).","journal-title":"Diabetes"},{"key":"2683_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.numecd.2006.07.008","volume":"18","author":"C de Oliveira Silva","year":"2008","unstructured":"de Oliveira Silva, C. et al. Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats. Nutr Metab Cardiovasc Dis \n                           18, 23\u201330 (2008).","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2683_CR54","doi-asserted-by":"publisher","first-page":"12098","DOI":"10.1038\/srep12098","volume":"5","author":"Y Zeng","year":"2015","unstructured":"Zeng, Y. et al. Hypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells. Sci Rep \n                           5, 12098 (2015).","journal-title":"Sci Rep"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02683-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02683-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02683-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:31:37Z","timestamp":1671769897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02683-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["2683"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-02683-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,23]]},"assertion":[{"value":"16 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2298"}}